A Study of Avutometinib (VS-6766) v. Avutometinib (VS-6766) + Defactinib in Recurrent Low-Grade Serous Ovarian Cancer With and Without a KRAS Mutation

Hopital Jean Minjoz, Besançon

UZ Leuven, Leuven

CHU de Liege, Liège

UZ Gent Medische Oncologie, Ghent

Memorial Sloan Kettering Cancer Center, New York

Hospital Universitario Reina Sofia, Córdoba

Insituto Europeo di Oncologia I.R.C.C.S, Milan

Virginia Cancer Specialists, PC, Gainesville

Maryland Oncology and Hematology, P.A., Glenn Dale

University of Virginia Health System, Charlottesville

Hospital Universitario Ramon y Cajal, Madrid

Advent Health, Orlando

H. Lee Moffitt Cancer Center and Research Institute - Center for Women's Oncology, Tampa

ICM - Val d'Aurelle, Montpellier

U.O.C. Oncologia 2, Istituto Oncologico Veneto I.R.C.C.S., Padua

Sarah Cannon Research Institute, Nashville

The Ohio State University Wexner Medical Center, Columbus

Cleveland Clinic Women's Health Institute, Cleveland

Hospital Clínico Universitario de Valencia, Valencia

Minnesota Oncology Hematology PA, Minneapolis

University of Chicago, Chicago

Washington University School of Medicine, St Louis

Centre Leon Berard, Lyon

University of Oklahoma Medical Center, Oklahoma City

Texas Oncology- Dallas Presbyterian Hospital, Dallas

Institut Curie, Paris

UT Southwestern Medical Center, Dallas

Texas Oncology, Longview

Texas Oncology, The Woodlands

Texas Oncology, San Antonio

Texas Oncology, McAllen

Texas Oncology Austin Central, Austin

Arizona Oncology Associates PC HAL, Scottsdale

University of New Mexico Comprehensive Cancer Center, Albuquerque

Comprehensive Cancer Centers of Nevada, Las Vegas

Sansum Clinic, Santa Barbara

Northwest Cancer Specialists, Portland

Willamette Valley Cancer Institute and Research Center, Eugene

Yale School of Medicine, New Haven

Centre de recherche di Centre Hospitalier de i'Universite de Montreal, Montreal

Princess Margaret Cancer Centre, Toronto

Hospital Universitario Vall D'Hebron, Barcelona

Western General Hospital, Edinburgh

Beatson West of Scotland Cancer Centre, Glasgow

UCLH Cancer Clinical Trials Unit, London

The Christie NHS Foundation Trust, Manchester

Royal Marsden Hospital, Sutton